Regional Conference, DILEMMAS AND CONTROVERSIES 3, Hotel Mediteran, Becici, Montenegro, 23.-25.04.2021.

Organizers: National Association for Enteral and Parenteral Nutrition-NUPENS, Section for Nutrition, Microbiota and Immunometabolism SLD, Section for Internal Medicine SLD, Association of Gastroenterologists of Serbia-Section of Young Gastroenterologists, South-East European Biologic & Regenerative Medicine Association-SEEBRA, Association Med- compass, Medical Chamber of Montenegro youth branch.

Read more HERE.

Another case of stem cells helping the recovery of a coronavirus patient.

A South Florida healthcare worker has battled back from coronavirus, and stem cells were key to her recovery.

Read and watch more HERE.

Report in paper Blic žena in Serbia about stem cells and COVID-19 treatment.

Read more HERE.

In China, 8 patients have been successfully treated with stem cell therapy and there are 14 ongoing clinical trials.

Read more HERE

In Israel, 6 severely ill patients were treated with stem cells at three medical institutions and all were cured.

Read more HERE

US researchers to study stem cell therapy in COVID-19 patients

The FDA has approved a clinical trial to study COVID-19 patients administered with umbilical cord-derived mesenchymal stem cells, which should prevent lung inflammation. The project leader is Dr Camillo Ricordi, study base: University of Miami Health System and Jackson Health System, Miami.

Read more HERE

Virtual international press conference

“Using stem cells in the treatment of severe forms of COVID infection”

Participants on the conference were experts from Slovenia, US and India as a

consortium frequently involved in the production of stem cells. One of the

participants also was an Italian doctor who applied stem cell therapy in Udine.

Clinical studies are fast track approved in China, America, Japan, Israel.

Watch the whole press conference HERE

For the first time, stem cell therapy has been successfully used to treat COVID-19 virus.

An international group of experts has successfully implemented new therapy in the first seven COVID-19 patients. All patients treated with stem cells survived. This type of therapy has already been successfully used for other serious immune diseases.

The first results were released this month. Such results are a hope for the ability of biological therapies to combat the COVID-19 pandemic.

Leng Zikuan, Zhu Rongjia, Hou Wei, et al. ACE2- Mesenchymal Stem Cells Transplantation Improves Patient Outcome with COVID-19 Pneumonia [J]. Aging and disease, 2020, 11 (2): 216-228

Stem cells and COVID-19 infection

An international group of experts has successfully applied new therapy to the first seven COVID-19 patients. All patients treated with a specific type of stem cell survived. Successful treatment of these patients, with an international consortium of experts, was performed at Beijing YouAn Hospital, Capital Medical University, China, with the approval and protocols of the Chinese Center for Disease Control and Prevention and the National Health Commissionof China.

Mesenchymal stem cell therapy belongs to the group of Advanced Cell Therapies. These therapies require sophisticated crafting technology. Resources are limited, so it certainly cannot be for widespread use and simpler forms. This therapy has a vital role to play for the survival of critically ill patients. These cell lines are produced by very few centers in the world, in Europe, Australia, India and Israel. From Europe there are centers in Germany, France and Turkey. There is also a Swiss company with facilities in Slovenia (MBSI – Educell), which specializes in the production of such cell therapies.

Dr Džihan Abazović talks about using stem cells to treat COVID-19 in the morning TV show

Watch Dr Džihan Abazović, co-president of the SEEBRA, in the morning TV show talking about using stem cells to treat COVID-19

Educell’s experimental cell therapy ImmunoART has a potential to reduce ARDS caused by COVID-19

Educell’s experimental mesenchymal stromal cell therapy ImmunoART has a potential to reduce ARDS (Acute Respiratory Distress Syndrome) caused by COVID-19